{"url_path":"/sec/curx/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2025942/0001493152-26-022892-index.html","accession_number":"0001493152-26-022892","cik":"0002025942","ticker":"CURX","issuer_name":"Curanex Pharmaceuticals Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/2025942/0001493152-26-022892-index.html","primary_entity_key":"0002025942","primary_entity_name":"Curanex Pharmaceuticals Inc"},"word_count":78,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nThere\nare no pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner\nof record or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to\nthe Company or has a material interest adverse to the Company. The Company’s property is not the subject of any pending legal proceedings."}